<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="66980">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01700439</url>
  </required_header>
  <id_info>
    <org_study_id>2011-02</org_study_id>
    <nct_id>NCT01700439</nct_id>
  </id_info>
  <brief_title>Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve</brief_title>
  <acronym>TRANSFORM™</acronym>
  <official_title>Multi-CenTer Experience With the Rapid Deployment EDWARDS INTUITY Valve System FOR Aortic Valve ReplaceMent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the clinical study is to prove that the heart valve device is safe,
      effective, and performs as intended.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, non-randomized, multi-center trial. Up to 950 subjects will be
      enrolled at up to 35 centers in the US. After re-placement of their aortic heart valve with
      the EDWARDS INTUITY valve system, each patient will have routine follow-up tests at the
      following intervals: discharge, 3 months, 1 year, and annually the-reafter for a minimum of
      five years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Long term Performance: Clinically acceptable function by echocardiogram</measure>
    <time_frame>All subjects will be assessed for clinical follow-up at the following intervals: Discharge, 1 mo., 3 mo., 1 yr and annually thereafter thru 5 yr follow-up per subject.</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The safety endpoints consist of mortality, valve thrombosis, thromboembolism, hemorrhage, paravalvular leak, endocarditis, structural and non-structural valve deterioration, explant, hemolysis, re-operation, and implant related new or worsening of a cardiac conduction issue.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic performance assessed by echocardiogram</measure>
    <time_frame>All subjects will be assessed for clinical follow-up at the following intervals: Discharge, 1 mo., 3 mo., 1 yr and annually thereafter thru 5 yr follow-up per subject.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Effectiveness endpoints consists of device technical success, cross-clamp time, cardiopulmonary bypass time, length of time in the intensive care unit, NYHA functional class compared to baseline, and hemodynamic performance of the heart valve device confirmed by echocardiography.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">950</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <condition>Aortic Valve Stenosis With Insufficiency</condition>
  <condition>Regurgitation, Aortic Valve</condition>
  <condition>Aortic Valve Incompetence</condition>
  <arm_group>
    <arm_group_label>EDWARDS INTUITY valve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects enrolled into the study are implanted with the EDWARDS INTUITY Valve System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EDWARDS INTUITY valve</intervention_name>
    <description>Surgical replacement of the aortic valve with the EDWARDS INTUITY valve.</description>
    <arm_group_label>EDWARDS INTUITY valve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion Criteria - Subjects will be required to meet all inclusion criteria:

               1. Male or female, age 18 years or older

               2. Has aortic stenosis or stenosis-insufficiency of an aortic valve requiring a
                  planned replace-ment as indicated in the preoperative evaluation

               3. Is scheduled to undergo planned aortic valve replacement with or without
                  concomitant coronary bypass surgery

               4. Provide written informed consent

               5. Geographically stable and agrees to attend follow-up assessments until all
                  subjects have completed 5 years of follow up

        Exclusion Criteria:

          -  Exclusion Criteria  - Subjects will not be eligible for trial participation if any of
             the following criteria are present:

               1. Pure aortic insufficiency

               2. Requires emergency surgery

               3. Previous aortic valve replacement

               4. Had prior mitral, tricuspid or pulmonic valve surgery, which included implant of
                  a bioprosthetic valve, mechanical valve, or annuloplasty ring that will remain
                  in situ

               5. Requires multiple valve replacement/repair

               6. Requires a surgical procedure outside of the cardiac area (e.g., vascular
                  endarterectomy, vascular bypass, tumor removal)

               7. Aneurysm of the aortic root and/or ascending aorta requiring surgical
                  intervention

               8. Active endocarditis/myocarditis or endocarditis/ myocarditis within 3 months
                  prior to the scheduled AVR surgery

               9. Myocardial infarction (MI) within thirty (30) days prior to valve replacement
                  surgery

              10. Renal insufficiency as determined by creatinine ≥ 2.5 mg/dL at screening or
                  end-stage renal disease requiring chronic dialysis

              11. Hyperparathyroidism

              12. MRI or CT-scan confirmed cerebrovascular accident (CVA), or transient ischemic
                  attack (TIA) within 6 months (180 days) of the procedure

              13. Presence of non-cardiac disease limiting life expectancy to less than 12 months

              14. Hypertrophic obstructive cardiomyopathy (HOCM)

              15. Left ventricular ejection fraction ≤ 25%

              16. Documented history of substance (drug or alcohol) abuse within the last 5 years

              17. Echocardiographic evidence of an intra-cardiac mass, thrombus, or vegetation

              18. Hemodynamic or respiratory instability requiring inotropic support, mechanical
                  circulatory support, or mechanical ventilation within 30 days prior to the
                  procedure

              19. Pregnancy, lactation, or planning to become pregnant;

              20. Currently incarcerated or unable to give voluntary informed consent

              21. Leucopenia (WBC &lt; 3.5x 103/µL), or acute anemia (Hgb &lt; 10.0 gm/dL or 6 mmol/L),
                  or thrombocytopenia (platelet count &lt; 50x 103/µL), or history of bleeding
                  diathesis or coagulopathy

              22. History of myxomatous disease/connective tissue disorders (e.g., Marfan's
                  Syndrome)

              23. Current or recent participation (within 6 weeks prior to surgery) in an
                  investigational drug or device trial

                  _____

                  Intra-operative Exclusion Criteria

              24. Anatomic variances which contraindicate implant of the trial valve, such as:

                    1. anomalous coronary arteries

                    2. annular deformation or extensive calcification of the annulus or aortic
                       root which cannot be removed

                    3. significant calcium on the anterior mitral leaflet

                    4. pronounced septal calcification

                    5. position of coronary ostia relative to Model 8300ACD valve that would
                       result in obstruction of blood flow

              25. Available devices are not suitably sized for the subject's annulus
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn Barnhart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Swedish Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Walter Randolph Chitwood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>East Carolina University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine Doorly</last_name>
    <email>catherine_doorly@edwards.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shawna Snodgrass, B.A, M.A.</last_name>
    <email>shawna_snodgrass@edwards.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Msgana Tamrat</last_name>
      <phone>310-825-1407</phone>
      <email>mtamrat@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Shemin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keck Hospital of University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Lopez, RN</last_name>
      <phone>323-442-6226</phone>
      <email>bmlopez@surgery.usc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Leticia Vasquez-Caldera, BA</last_name>
      <phone>323-442-6225</phone>
      <email>Leticia.vasquez-caldera@med.usc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Vaughn Starnes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hoag Memorial Hospital Presbyterian</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Perez, RN</last_name>
      <phone>949-764-4509</phone>
      <email>amy.perez@hoag.org</email>
    </contact>
    <contact_backup>
      <last_name>Cathy Major, RN</last_name>
      <phone>949-764-1469</phone>
      <email>cathy.major@hoag.org</email>
    </contact_backup>
    <investigator>
      <last_name>Aidan A Raney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Brainerd, RN, BSN</last_name>
      <phone>916-453-4161</phone>
      <email>Sandra.Brainerd@DignityHealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Deirdre Harris, RN, BSN</last_name>
      <phone>916-733-6290</phone>
      <email>Deirdre.Harris@DignityHealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Allen Morris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beverly Mansker, RN</last_name>
      <phone>407-303-7556</phone>
      <email>Beverly.Mansker@flhosp.org</email>
    </contact>
    <contact_backup>
      <last_name>Melissa Leonard, RN MBA CCRP</last_name>
      <phone>407-303-7556</phone>
      <email>melissa.leonard@flhosp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kevin Accola, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Huskin, RN, BSN, CCRC</last_name>
      <phone>312-695-4067</phone>
      <email>ahuskin@nmh.org</email>
    </contact>
    <investigator>
      <last_name>Patrick McCarthy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Trovato, BS</last_name>
      <phone>617-632-7488</phone>
      <email>mtrovato@bidmc.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lauren Mills, RN</last_name>
      <phone>617-632-9228</phone>
      <email>lpmills@bidmc.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kamal Khabbaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Michigan Medical School</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nickole Carlson, RN,BSN,CCRP</last_name>
      <phone>734-232-4780</phone>
      <email>ngarvey@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Taylor, RN,BSN,MSN</last_name>
      <phone>734-936-9664</phone>
      <email>jestaylo@med.umich.edu</email>
    </contact_backup>
    <investigator>
      <last_name>G Michael Deeb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University - Barnes Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Koogler, RN, BSN</last_name>
      <phone>314-362-3043</phone>
      <email>kooglerk@wudosis.wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Joann Marsala, RN</last_name>
      <phone>314-747-4547</phone>
      <email>marsalai@wudosis.wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ralph Damiano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Corut</last_name>
      <phone>856-968-7366</phone>
      <email>corut-sandra@cooperhealth.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Rosenbloom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Shore Long Island Jewish Health System</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason McGrade, PA</last_name>
      <phone>516-562-4489</phone>
      <email>JmcGrade@nshs.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lynda Jahn, ANP</last_name>
      <phone>516-562-2851</phone>
      <email>ljahn@nshs.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alan Hartman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Ursomanno, Ph.D</last_name>
      <phone>212-263-1064</phone>
      <email>patricia.ursomanno@nyumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Annette Rabinovich, BA</last_name>
      <phone>212-263-7585</phone>
      <email>annette.rabinovich@nyumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Didier Loulmet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mission Hospital</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Riggsbee, RN</last_name>
      <phone>828-213-7033</phone>
      <email>Christina.Riggsbee@msj.org</email>
    </contact>
    <contact_backup>
      <last_name>On-call Research Nurse</last_name>
      <phone>828-213-1327</phone>
    </contact_backup>
    <investigator>
      <last_name>Mark Groh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Sutton, CCRP,CRC II</last_name>
      <phone>919-668-2382</phone>
      <email>victoria.sutton@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Donald Glower, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Carolina University</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malissa Harris, RN BSN CCRC</last_name>
      <phone>252-744-5287</phone>
      <email>harrismal@ecu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Brenda Akers, RN BSN</last_name>
      <phone>252-744-8482</phone>
      <email>akersbr@ecu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alan P. Kypson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Hein, RN BSN CCRN</last_name>
      <phone>513-862-2877</phone>
      <email>angela_hein@trihealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Carol Krabbe, RN BSN CCRN</last_name>
      <phone>513-862-2877</phone>
      <email>Carol_Krabbe@trihealth.com</email>
    </contact_backup>
    <investigator>
      <last_name>J. Michael Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Sankovic, RN, CCRP</last_name>
      <phone>216-445-6916</phone>
      <email>sankovk@ccf.org</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Garcia, RN,BSN, CCRC</last_name>
      <phone>216-442-5234</phone>
      <email>GARCIAM1@ccf.org</email>
    </contact_backup>
    <investigator>
      <last_name>Joseph Sabik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health at Harrisburg Hospital</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Regina Hollister, RN</last_name>
      <phone>717-731-0101</phone>
      <phone_ext>3152</phone_ext>
      <email>rhollister@pinnaclehealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Anita Todd, RN</last_name>
      <phone>717-731-0101</phone>
      <phone_ext>3002</phone_ext>
      <email>atodd@pinnaclehealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Mubashir Mumtaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rohan Menon</last_name>
      <phone>412-609-6325</phone>
      <email>Rohan.Menon@uphs.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth K Walsh, RN</last_name>
      <phone>215-662-4289</phone>
      <email>Lisa.Walsh@uphs.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Y Joseph Woo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Enlow</last_name>
      <phone>412-647-1582</phone>
      <email>enlowms@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Valchar</last_name>
      <phone>412-647-7271</phone>
      <email>valcharka@upmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Vinay Badhwar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Gleason, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Memorial Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Porter, RN, CNOR, CCRC</last_name>
      <phone>901-747-1262</phone>
      <email>charlotte@cvsclinic.com</email>
    </contact>
    <investigator>
      <last_name>H Edward Garrett Jr., MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Thomas Health</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Orga, RN</last_name>
      <phone>615-222-3083</phone>
      <email>JAN.ORGA@STH.ORG</email>
    </contact>
    <contact_backup>
      <last_name>Nancy Grimes, RN</last_name>
      <phone>615-222-4356</phone>
      <email>ngrimes@sth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Evelio Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical City Dallas Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tricia Snelus</last_name>
      <phone>972-566-6389</phone>
      <email>tsnelus@crsti.org</email>
    </contact>
    <contact_backup>
      <last_name>Jill Fowler</last_name>
      <phone>972-566-6389</phone>
      <email>jfowler@crsti.org</email>
    </contact_backup>
    <investigator>
      <last_name>Todd M Dewey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cecile Mahoney</last_name>
      <phone>972-566-5617</phone>
      <email>cmahoney@crsti.org</email>
    </contact>
    <contact_backup>
      <last_name>Jill Fowler</last_name>
      <phone>972-566-6389</phone>
      <email>jfowler@crsti.org</email>
    </contact_backup>
    <investigator>
      <last_name>William H Ryan, III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Tinlin</last_name>
      <phone>206-215-2455</phone>
      <email>deborah.tinlin@swedish.org</email>
    </contact>
    <contact_backup>
      <last_name>Tracie Granger</last_name>
      <phone>206-215-2466</phone>
      <email>tracie.granger@swedish.org</email>
    </contact_backup>
    <investigator>
      <last_name>Glenn R Barnhart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora St Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Zywicki, RN</last_name>
      <phone>414-385-2474</phone>
      <email>Cheryl.zywicki@aurora.org</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Cooper, RN</last_name>
      <phone>414-385-2504</phone>
      <email>Jennifer.cooper@aurora.org</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel O'Hair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 12, 2014</lastchanged_date>
  <firstreceived_date>September 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic valve</keyword>
  <keyword>Heart valve</keyword>
  <keyword>Tissue valve</keyword>
  <keyword>Bioprosthesis</keyword>
  <keyword>Valve disorder</keyword>
  <keyword>Valve disease</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>Less invasive cardiac surgery</keyword>
  <keyword>Aortic valve stenosis</keyword>
  <keyword>Aortic valve regurgitation</keyword>
  <keyword>Bovine pericardium</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
